-
公开(公告)号:US20190247446A1
公开(公告)日:2019-08-15
申请号:US16318583
申请日:2017-07-18
申请人: AOBIOME LLC
IPC分类号: A61K35/741 , A61K9/00 , A61K9/02 , A61K45/06 , A61K33/00 , A61K47/02 , A61K9/08 , A23L33/135
CPC分类号: A61K35/741 , A23L33/135 , A23V2002/00 , A61K9/0031 , A61K9/0043 , A61K9/0053 , A61K9/0056 , A61K9/006 , A61K9/0073 , A61K9/02 , A61K9/08 , A61K33/00 , A61K35/74 , A61K45/06 , A61K47/02 , A61K2035/115 , Y02A50/473 , Y02A50/475 , Y02A50/481
摘要: Ammonia oxidizing microorganism preparations for delivery to the gastrointestinal system, kits including ammonia oxidizing preparations for delivery to the gastrointestinal system, and devices for administering ammonia oxidizing preparations to the gastrointestinal system are provided. Methods of introducing ammonia oxidizing microorganisms to the gastrointestinal system are provided. Methods of treating disorders, including gastrointestinal disorders and inflammatory disorders, with ammonia oxidizing microorganism preparations are provided.
-
公开(公告)号:US20190240268A1
公开(公告)日:2019-08-08
申请号:US16353474
申请日:2019-03-14
发明人: Shigeki KOSHIDA , Masaki TERAHARA
IPC分类号: A61K35/745 , A61K47/36 , A61K35/74
CPC分类号: A61K35/745 , A61K35/74 , A61K47/36
摘要: Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.
-
公开(公告)号:US20190231871A1
公开(公告)日:2019-08-01
申请号:US16193724
申请日:2018-11-16
IPC分类号: A61K39/395 , A61K35/741 , G01N33/68 , C07K16/18 , A61K35/74
CPC分类号: A61K39/3955 , A61K35/74 , A61K35/741 , A61K2039/505 , C07K16/18 , G01N33/6896 , G01N2800/28 , G01N2800/7076 , G01N2800/7085
摘要: Disclosed herein are compositions, systems, and methods for diagnosing and treatment of subjects suffering from anxiety, autism spectrum disorder (ASD), or a pathological condition with one or more of the symptoms of ASD.
-
4.
公开(公告)号:US20190216864A1
公开(公告)日:2019-07-18
申请号:US16368655
申请日:2019-03-28
申请人: PROBIOTICAL S.P.A.
发明人: Giovanni MOGNA , Gian Paolo STROZZI , Luca MOGNA
IPC分类号: A61K35/745 , A23L33/135 , C12R1/01
CPC分类号: A61K35/745 , A23L33/135 , A61K35/74 , C12R1/01 , Y02A50/47 , Y02A50/473 , Y02A50/481
摘要: Selection of probiotic strains belonging to the genus Bifidobacterium and to a symbiotic composition containing the same for use of feeding infants, is described.
-
5.
公开(公告)号:US20190209634A1
公开(公告)日:2019-07-11
申请号:US15563617
申请日:2017-06-01
发明人: Karen Vieira
IPC分类号: A61K36/31 , A61K36/53 , A61K35/04 , A61K35/748 , A61K36/185 , A61K31/4525 , A61K36/67 , A61K9/00 , A61K9/48 , A61K36/61 , A61K36/48 , A61K36/9066 , A61P39/06 , A61P3/10 , A61P3/06
CPC分类号: A61K36/31 , A61K9/0053 , A61K9/48 , A61K31/4525 , A61K35/04 , A61K35/74 , A61K35/748 , A61K36/185 , A61K36/47 , A61K36/48 , A61K36/53 , A61K36/61 , A61K36/67 , A61K36/9066 , A61K2300/00 , A61P3/06 , A61P3/10 , A61P39/06
摘要: The main objective of the present invention is to develop an herbal formulation with high polyphenol concentrations. A therapeutic effect of ingredients in herbal composition with Antioxidants, Anti-inflammatories, Anti Viral & Anti Microbial properties to reduce Oxidative Stress, Inflammation, Viral and Microbial Infections. The herbal composition promotes management of diabetes, regulation of cholesterol, also immune system processes that helps to fight against viral and bacterial infections, colds, or the flu, skin ailments such as Psoriasis & eczema. Herbal Composition comprises synergistic combination of Moringa Oleifera Leaf Powder, Spirulina & Aqueous extracts of Oregano Vulgare Leaf Extract, Shilajit extract, Rosemary Leaf extract, Pomegranate Fruit Preel extract, Amla fruit extract, Fenugreek Seed Extract, Curcumin Extract, Piperine extract. Therefore, the chosen herbal blend provides the body with all of the vitamins, minerals, and nutrients it needs to continuously boost health.
-
公开(公告)号:US20190201704A1
公开(公告)日:2019-07-04
申请号:US16292662
申请日:2019-03-05
申请人: NANOBACTERIE
IPC分类号: A61N1/40 , A61K33/26 , C12N1/20 , A61N2/00 , A61K41/00 , A61K9/00 , C12N1/38 , A61K9/51 , A61K9/10 , A61K35/74
CPC分类号: A61N1/406 , A61K9/0019 , A61K9/10 , A61K9/51 , A61K9/5146 , A61K33/26 , A61K35/74 , A61K41/0052 , A61N2/00 , C12N1/20 , C12N1/38
摘要: A method for the treatment of tumor(s) or tumor cell(s) or cancer(s) in a subject in need by the generation of heat. The latter is produced by chains of magnetosomes extracted from whole magnetotactic bacteria and subjected to an alternating magnetic field. These chains of magnetosomes yield efficient antitumoral activity whereas magnetosomes unbound from the chains or kept within the whole bacteria produce poor or no antitumoral activity. The introduction of various chemicals such as chelating agents and/or transition metals within the growth medium of the bacteria improves the heating properties of the chains of magnetosomes. Moreover, the insertion of the chains of magnetosomes within a lipid vesicle is also suggested in order to favor their rotation in vivo and hence to improve their heating capacity. The vesicle can contain an antitumoral agent together with the chains of magnetosomes. In this case, the agent is released within the tumors by heating the vesicle.
-
公开(公告)号:US20190201479A1
公开(公告)日:2019-07-04
申请号:US16325629
申请日:2017-08-14
摘要: The present disclosure provides, in some embodiments, compositions, kits, systems, and methods for reducing bacteria on a surface (e.g., a medical device) and preventing and/or treating a bacterial infection (e.g., urinary tract infection) in a subject using IdsD protein or a fragment thereof.
-
公开(公告)号:US20190201457A1
公开(公告)日:2019-07-04
申请号:US16328303
申请日:2017-08-31
发明人: Peter Q. Nguyen , Neel Satish Joshi
CPC分类号: A61K35/74 , A61K9/0031 , A61K9/0056 , A61K9/02 , A61K9/20 , A61K9/48 , A61P1/00 , C07K14/245 , C07K19/00 , C07K2317/622 , C07K2319/02 , C07K2319/036 , C07K2319/21 , C12P21/02
摘要: Engineered bacteria that secrete therapeutic polypeptides, pharmaceutical compositions comprising the bacteria, methods for producing recombinant polypeptides, and methods for using the bacteria for diagnostic and therapeutic purposes are provided.
-
9.
公开(公告)号:US20190183943A1
公开(公告)日:2019-06-20
申请号:US16329186
申请日:2017-06-09
申请人: COENBIO CO., LTD.
发明人: Kyu Jin YUM
IPC分类号: A61K35/744 , A23L33/135 , A61Q7/00 , A61K9/00 , A61K8/99 , A61K35/747 , A61K35/745 , A61P3/06 , A61P15/10 , C12R1/01 , A61P17/14
CPC分类号: A61K35/744 , A23L33/135 , A23V2002/00 , A23Y2220/35 , A23Y2260/35 , A61K8/99 , A61K9/00 , A61K9/0029 , A61K9/0053 , A61K35/74 , A61K35/745 , A61K35/747 , A61K2035/115 , A61P3/06 , A61P15/10 , A61P17/14 , A61Q7/00 , C12N1/20 , C12R1/01
摘要: The present invention relates to a novel Leuconostoc holzapfelii Ceb-kc-003 (deposited as Korea Accession Number accession KCCM11830P) strain and a composition comprising the same. The novel strain has abilities of preventing hair loss, promoting hair growth, or improving sexual function.
-
10.
公开(公告)号:US20180353557A1
公开(公告)日:2018-12-13
申请号:US16105467
申请日:2018-08-20
IPC分类号: A61K35/747 , A23K10/16 , A23K10/18 , A23L33/135 , A61K39/145 , A61K35/74 , A23K10/12 , C12R1/225 , A23L2/52 , A61K35/00 , A61K39/00
CPC分类号: A61K35/747 , A23K10/12 , A23K10/16 , A23K10/18 , A23L2/52 , A23L33/135 , A23V2002/00 , A23Y2220/63 , A61K35/74 , A61K39/145 , A61K2035/11 , A61K2039/523 , C12R1/225
摘要: A method for prophylaxis or treatment of a disease includes administering an an effective amount of an agent that contains cells of Lactobacillus paracasei MCC1849 (NITE BP-01633) to a subject in need of such prophylaxis or treatment. The disease can be one or more of an inflammatory disease, ulcer, food allergies, bronchial asthma, urticaria, pollinosis, anaphylactic shock or an opportunistic infection.
-
-
-
-
-
-
-
-
-